1. Home
  2. FGEN vs BGI Comparison

FGEN vs BGI Comparison

Compare FGEN & BGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • BGI
  • Stock Information
  • Founded
  • FGEN 1993
  • BGI 1879
  • Country
  • FGEN United States
  • BGI Canada
  • Employees
  • FGEN N/A
  • BGI N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • BGI
  • Sector
  • FGEN Health Care
  • BGI
  • Exchange
  • FGEN Nasdaq
  • BGI Nasdaq
  • Market Cap
  • FGEN 33.5M
  • BGI 17.8M
  • IPO Year
  • FGEN 2014
  • BGI 2005
  • Fundamental
  • Price
  • FGEN $7.44
  • BGI $0.85
  • Analyst Decision
  • FGEN Strong Buy
  • BGI
  • Analyst Count
  • FGEN 1
  • BGI 0
  • Target Price
  • FGEN $250.00
  • BGI N/A
  • AVG Volume (30 Days)
  • FGEN 66.4K
  • BGI 93.6K
  • Earning Date
  • FGEN 08-05-2025
  • BGI 07-22-2025
  • Dividend Yield
  • FGEN N/A
  • BGI N/A
  • EPS Growth
  • FGEN N/A
  • BGI N/A
  • EPS
  • FGEN N/A
  • BGI N/A
  • Revenue
  • FGEN $6,996,000.00
  • BGI $131,596,265.00
  • Revenue This Year
  • FGEN N/A
  • BGI N/A
  • Revenue Next Year
  • FGEN N/A
  • BGI N/A
  • P/E Ratio
  • FGEN N/A
  • BGI N/A
  • Revenue Growth
  • FGEN N/A
  • BGI 4.01
  • 52 Week Low
  • FGEN $4.50
  • BGI $0.76
  • 52 Week High
  • FGEN $38.25
  • BGI $2.95
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 64.36
  • BGI 40.24
  • Support Level
  • FGEN $7.03
  • BGI $0.81
  • Resistance Level
  • FGEN $5.73
  • BGI $0.98
  • Average True Range (ATR)
  • FGEN 0.50
  • BGI 0.07
  • MACD
  • FGEN 0.35
  • BGI -0.01
  • Stochastic Oscillator
  • FGEN 100.00
  • BGI 23.53

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About BGI Birks Group Inc.

Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.

Share on Social Networks: